03:12 PM EDT, 08/27/2025 (MT Newswires) -- Health care stocks advanced late Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) fractionally higher.

The iShares Biotechnology ETF (IBB) was up 0.1%.

In corporate news, Moderna ( MRNA ) said the US Food and Drug Administration approved its supplemental biologics license applications for the updated 2025-2026 formulas of Spikevax and mNexspike vaccines, which target the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. Moderna ( MRNA ) shares rose 0.8%.